At what enterprise value was VITAMIN WELL acquired in 2024?

During the acquisition of VITAMIN WELL by CINVEN in 2024, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the AgriFood industry currently tracks an average EBITDA multiple of 10.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of VITAMIN WELL when it was acquired by CINVEN?

The estimated EV/EBITDA multiple for VITAMIN WELL is in the range of 15x - 25x. For comparison, the AgriFood sector currently shows an average EBITDA multiple of 10.6x. Join our community for free to access full valuation data and industry trends.

When was VITAMIN WELL acquired by CINVEN?

VITAMIN WELL was acquired by CINVEN in 2024.

What was the revenue of VITAMIN WELL at the time of the deal?

The revenue of VITAMIN WELL at the time of the deal is estimated to be in the range of 450M - 900M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of VITAMIN WELL during the acquisition?

VITAMIN WELL's EBITDA is estimated to be in the range of 100M - 200M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the VITAMIN WELL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the VITAMIN WELL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cinven.com/news-insights/cinven-to-become-lead-investor-in-vitamin-well/

← DATABASE

Home Database AgriFoodVITAMIN WELL

08/2024

CINVEN

takes majority stake in

VITAMIN WELL

SWEDEN Food Processing / Beverages / Soft Drinks EV 1b - 4b EUR

CINVEN takes majority stake in VITAMIN WELL

SWEDEN Food Processing / Beverages / Soft Drinks EV 1b - 4b EUR

Context

The acquisition of Vitamin Well by Cinven is a strategic move to capitalize on the growing demand for healthier and more active lifestyles. The deal is driven by the attractive characteristics of the health, wellbeing, and fitness sector, which is underpinned by a structural shift away from less healthy snacks and drinks. Vitamin Well's well-established position in the market, its portfolio of high-quality brands, and its track record of profitable organic growth make it an attractive investment opportunity for Cinven. The firm's experience in investing in the Consumer sector and its knowledge of the Nordic region will be leveraged to support Vitamin Well's management team in delivering their ambitious targets. The deal is expected to drive growth and expansion for Vitamin Well, both in its existing markets and through international expansion. The partnership between Cinven, Bridgepoint, and Vitamin Well's management team is expected to create a strong platform for the company's future success, with a focus on driving innovation, improving operational efficiency, and increasing profitability.

VITAMIN WELL, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the AgriFood sector (10.6x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in AgriFood market trends

Target

Vitamin Well is a Swedish provider of protein bars and sport and health beverages, established in 2008 and headquartered in Stockholm. The company offers premium products for health-conscious and active consumers, with a broad product portfolio across several brands, including Vitamin Well, NOCCO, and Barebells. These brands are sold internationally across more than 40 markets, catering to the growing demand for healthier and more active lifestyles. Vitamin Well's business model is centered around the development, manufacturing, and distribution of high-quality, differentiated products that receive excellent feedback on taste, texture, and nutrition. The company has a strong and experienced management team, with a track record of profitable organic growth, innovation, and investment in product development. Vitamin Well's revenue generation is primarily driven by the sales of its products through various distribution channels, including wholesale, retail, and online platforms. The company's key assets include its portfolio of brands, manufacturing facilities, and a strong distribution network.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Other operations with VITAMIN WELL

Date	Acquirer	Target	Country	Sector	Deal Context
11/2016	BRIDGEPOINT	VITAMIN WELL	SWEDEN	Food Processing	The investment by Bridgepoint Development Capital in Vitamin Well marks a significant milestone in the company's growth journey, providing it with the necessary capital and expertise to further expand its market presence and accelerate its growth trajectory. The transaction, which is subject to merger clearance, is expected to close before the end of the first quarter of 2017, and will enable Vitamin Well to leverage Bridgepoint Development Capital's extensive network and expertise to drive its strategic growth initiatives. With its strong track record of investing in high-growth businesses, Bridgepoint Development Capital is well-positioned to support Vitamin Well's ambitions, and the partnership is expected to create significant value for all stakeholders. The investment will also enable Vitamin Well to enhance its product offerings, expand its distribution channels, and strengthen its market position, ultimately driving long-term growth and profitability.

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 450M - 900M EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VITAMIN WELL by CINVEN are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: vitamin well

Acquirer: cinven